MS
Mehta Sarang
About Mehta Sarang
Data last updated:
Mehta Sarang is a Director at Denvia Pharmaceuticals Private Limited (since 2026) and Designated Partner at Mehta Digital Ventures Llp (since 2017). The companies operate in Education & Learing.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Denvia Pharmaceuticals Private Limited U21000KA2026PTC226293 | Director | 18 Aug 2026 | 2026 | Active | |
| Mehta Digital Ventures Llp AAI-8187 | Designated Partner | 13 Mar 2017 | 2017 | Active |
Board colleagues of Mehta Sarang
| Name | DIN | Company | Designation |
|---|---|---|---|
| Arun Kumar Veerashetty Beknal | 11898482 | Denvia Pharmaceuticals Private Limited | Director |
| Dandin Vishwanath | 11898481 | Denvia Pharmaceuticals Private Limited | Director |
| Rajshree Gilada | 03018312 | Denvia Pharmaceuticals Private Limited | Director |
| Ravindrakumar Beknal | 11898483 | Denvia Pharmaceuticals Private Limited | Director |
| Megha Sarang Mehta | 07702283 | Mehta Digital Ventures Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mehta Sarang
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mehta Sarang
Mehta Sarang currently holds 2 directorships: Denvia Pharmaceuticals Private Limited (Director, since 18 Aug 2026); Mehta Digital Ventures Llp (Designated Partner, since 13 Mar 2017).
Mehta Sarang was first appointed on 13 Mar 2017 as Designated Partner at Mehta Digital Ventures Llp. The most recent appointment on record is 18 Aug 2026 at Denvia Pharmaceuticals Private Limited.
The current boards of Mehta Sarang's companies include Arun Kumar Veerashetty Beknal (Denvia Pharmaceuticals Private Limited), Dandin Vishwanath (Denvia Pharmaceuticals Private Limited), Rajshree Gilada (Denvia Pharmaceuticals Private Limited), Ravindrakumar Beknal (Denvia Pharmaceuticals Private Limited), Megha Sarang Mehta (Mehta Digital Ventures Llp).